Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(55)
•••
Comment by frohlir944on Dec 27, 2018 10:21pm
133 Views
Post# 29162740

RE:RE:RE:RE:RE:DOW Largest Up Day Ever!! Over a 1000 Points!

RE:RE:RE:RE:RE:DOW Largest Up Day Ever!! Over a 1000 Points!Must be hard work to be wrong incessantly.  Bought my first large lot in 2012 and have been adding ( including around the $2 mark) ever since.  I actually logged into my account to see, no guessing on my part.  Have added almost 100 times since then.  So I actually understand.  But it’s people like you that constantly undermine their own (and mine) investment that I find both perplexing and irritating.   It’s not the effect on me that I’m worried about,  I believe in the science and on the extraordinary team that is currently implementing it,  it’s the effect of your negativity on all those American investors that you are so keen on attracting that are new to the story that I’m worried about.  If only there was a GLOBAL ignore button .
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities